Conference News In Brief: Attorneys Watching FDA’s ING Guidance; PCPC Priorities; More
This article was originally published in The Rose Sheet
Executive Summary
Legal experts at an ACI regulatory forum on cosmetics stressed the importance of submitting comments on recently released FDA guidance that could potentially obligate firms studying cosmetic ingredients to file Investigation New Drug Applications. Meanwhile, PCPC Board Chairman Scott Beattie provided an overview of key initiatives for the year at the trade group’s annual meeting in Palm Beach, Fla.